SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,606 | -8.3% | 15,800 | 0.0% | 0.06% | 0.0% |
| Q2 2023 | $474,948 | -17.0% | 15,800 | 0.0% | 0.06% | -14.1% |
| Q1 2023 | $572,434 | +11.4% | 15,800 | +9.7% | 0.07% | +10.9% |
| Q4 2022 | $513,648 | +38.1% | 14,400 | +30.9% | 0.06% | +25.5% |
| Q3 2022 | $372,000 | +17.0% | 11,000 | 0.0% | 0.05% | +27.5% |
| Q2 2022 | $318,000 | -10.7% | 11,000 | 0.0% | 0.04% | +8.1% |
| Q1 2022 | $356,000 | – | 11,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |